Gender‐Related Outcomes in Saphenous Vein Graft Interventions
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.31336 ↗At a glance
Vergleichsstudie in Catheterization and Cardiovascular Interventions, 2025. Written by Azriel Osherov and 9 co-authors. Institution: Department of Cardiology, Barzilai Medical Center, Ashkelon, Israel. Major MEDLINE topics: Saphenous Vein, Coronary Artery Bypass, Graft Occlusion, Vascular, Percutaneous Coronary Intervention. 28 references. Funded by: The authors received no specific funding for this work..
Abstract (original language)
Background
Saphenous vein graft percutaneous coronary intervention (SVG‐PCI) is a relatively common procedure in patients after coronary artery bypass grafting (CABG). Although internal mammary artery is considered optimal, SVG is still used in the majority of patients.
Aims
Investigating the potential role of gender differences in the incidence and outcomes of SVG‐PCI.
Methods
The study was based on a prospectively collected registry of 1199 consecutive patients (169 female) who underwent SVG‐PCI in a tertiary medical center between 2004 and 2023. Primary outcomes included MACE (death, myocardial infarction [MI], target vessel revascularization [TVR], stroke) and mortality, at 1 and 3 years.
Results
Female patients were older (73.6 ± 9.1 years vs. 70.6 ± 9.7 years, p < 0.001), suffered from higher rates of diabetes mellitus, peripheral vascular disease, and congestive heart failure (78.1% vs. 61.3% p < 0.001, 13.6% vs. 7% p < 0.003, 66.3% vs. 51.8% p < 0.001 respectively). Additionally, female patients had lower trans‐radial access use (11.9% vs. 19.3%, p < 0.025), and underwent SVG‐PCI earlier following their CABG procedure (11.3 ± 6.2 years vs 12.9 ± 6.1 years, p < 0.003), as compared to male patients. There were no differences in MACE rates between the groups. Mortality was higher in the female group at 1 year (13.6% vs. 6.9%, p = 0.003), but no significant differences were observed at 3 years (24.3% vs. 20.9%, p = 0.320). Cox regression analysis identified age, renal function, ejection fraction, MI and trans‐femoral as independent risk factors for mortality.
Conclusion
Gender‐specific monitoring and early intervention, especially for women, are required for better management of graft patency, potentially improving long‐term outcomes.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Cardiology, Barzilai Medical Center, Ashkelon, Israel.
- The Faculty of Medicine, Ben-Gurion University, Beer-Sheva, Israel.
- Department of Cardiology, Rabin Medical Center, Petach Tikva, Israel.
- Beilinson and Hasharon Hospitals, The Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
ORCID profiles: Azriel Osherov, Leor Perl, Enrique Gallego-Colon, Ran Kornowski, Mark Kheifets
Funding
- The authors received no specific funding for this work.
Cite
APA
Osherov, A., Perl, L., Gallego-Colon, E., Furman, A., Bental, T., Levi, A., Vaknin-Assa, H., Codner, P., Kornowski, R., & Kheifets, M. (2025). Gender‐Related Outcomes in Saphenous Vein Graft Interventions. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31336
Vancouver
Osherov A, Perl L, Gallego-Colon E, Furman A, Bental T, Levi A, et al. Gender‐Related Outcomes in Saphenous Vein Graft Interventions. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31336
BibTeX
@article{Osherov2025,
author = {Osherov, Azriel and Perl, Leor and Gallego-Colon, Enrique and Furman, Aryel and Bental, Tamir and Levi, Amos and Vaknin-Assa, Hana and Codner, Pablo and Kornowski, Ran and Kheifets, Mark},
title = {Gender‐Related Outcomes in Saphenous Vein Graft Interventions},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.31336}
}
EUVIMED